SHOULD THE DOSE OF HEPATITIS B VACCINE BE REDUCED IN NEWBORN BABIES?
- 1 November 1987
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 330 (8569) , 1218-1219
- https://doi.org/10.1016/s0140-6736(87)91360-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- VERY-LOW-DOSE HEPATITIS B VACCINE IN NEWBORN INFANTS: AN ECONOMIC OPTION FOR CONTROL IN ENDEMIC AREASThe Lancet, 1987
- LOW-DOSE HEPATITIS B VACCINE IMMUNISATION IN CHILDRENThe Lancet, 1987
- HEPATITIS B IMMUNISATION WITH A REDUCED NUMBER OF DOSES IN NEWBORN BABIES AND CHILDRENThe Lancet, 1985
- IMMUNOGENICITY OF LOW DOSE (1·25 AND 0·31 µg) HEPATITIS B VACCINEThe Lancet, 1984
- IMMUNOGENICITY AND SAFETY OF A PLASMA-DERIVED HEAT-INACTIVATED HEPATITIS B VACCINE (CLB)American Journal of Epidemiology, 1984
- PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULINThe Lancet, 1984
- PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINEThe Lancet, 1983